Filgotinib for bDMARD-refractory rheumatoid arthritis

被引：0
|
作者：
Clark, Anna
机构：
来源：
LANCET RHEUMATOLOGY | 2019年 / 1卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E11 / E11
页数：1
相关论文
共 50 条
  • [1] Filgotinib in rheumatoid arthritis
    Westhovens, Rene
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2023, 19 (02) : 135 - 144
  • [2] Filgotinib for rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2021, 3 (03): : E174 - E174
  • [3] Combining ts- and a bDMARD in refractory rheumatoid arthritis: an unusual adverse event
    Sztejkowski, Cedric
    Sibilia, Jean
    Danion, Francois
    Mertz, Philippe
    Elodie, Fels
    Kassegne, Loic
    Boyer, Pierre
    Puechal, Xavier
    Gottenberg, Jacques-Eric
    Scherlinger, Marc
    RHEUMATOLOGY, 2024, 63 (06) : e185 - e187
  • [4] Filgotinib as rheumatoid arthritis therapy
    Becciolini, A.
    Di Donato, E.
    Santilli, D.
    Lucchini, G.
    Mozzani, F.
    Riva, M.
    Ariani, A.
    DRUGS OF TODAY, 2021, 57 (09) : 543 - 550
  • [5] Safety of filgotinib in rheumatoid arthritis
    Thorley, Jennifer
    LANCET RHEUMATOLOGY, 2024, 6 (07): : E421 - E421
  • [6] Filgotinib for the treatment of rheumatoid arthritis
    Taylor, Peter C.
    Azeez, Maha Abdul
    Kiriakidis, Serafim
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2017, 26 (10) : 1181 - 1187
  • [7] Evaluating filgotinib for the treatment of rheumatoid arthritis
    Richez, Christophe
    Truchetet, Marie-Elise
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (18) : 2435 - 2444
  • [8] FILGOTINIB IN PATIENTS WITH RHEUMATOID ARTHRITIS AND PRIOR INADEQUATE RESPONSE OR INTOLERANCE TO BIOLOGICAL DMARDS (BDMARD-IR) BY RACE & GEOGRAPHIC REGION
    Gottenberg, Jacques-Eric
    Genovese, Mark C.
    Kalunian, Kenneth
    Mozaffarian, Neelufar
    Bartok, Beatrix
    Matzkies, Franziska
    Gao, Jie
    Guo, Ying
    Walker, David
    Takeuchi, Tsutomu
    de Vlam, Kurt
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 361 - 361
  • [9] A Subgroup Analysis of the Efficacy of Filgotinib in Demographic and Clinical Subgroups of Patients with Refractory Rheumatoid Arthritis
    Kalunian, Kenneth
    Genovese, Mark
    Gottenberg, Jacques-Eric
    Bartok, Beatrix
    Pechonkina, Alena
    Guo, Ying
    Tasset, Chantal
    Sundy, John
    de Vlam, Kurt
    Walker, David
    Takeuchi, Tsutomu
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [10] A Composite IFN-Based Signature Is Associated with a Filgotinib-Specific Clinical Response in bDMARD-Experienced Rheumatoid Arthritis Patients
    Taylor, Peter
    Downie, Bryan
    Elboudwarej, Emon
    Hawtin, Rachael
    Mirza, Amer M.
    Liu, Jinfeng
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345